A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.

Authors

Dee Anna Glaser
Adelaide A Hebert
Alexander Nast
William P Werschler
Lawrence Green, George Washington University
Richard D Mamelok
John Quiring
Janice Drew
David M Pariser

Document Type

Journal Article

Publication Date

5-20-2019

Journal

American journal of clinical dermatology

DOI

10.1007/s40257-019-00446-6

Comments

Epub ahead of print

APA Citation

Glaser, D., Hebert, A., Nast, A., Werschler, W., Green, L., Mamelok, R., Quiring, J., Drew, J., & Pariser, D. (2019). A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.. American journal of clinical dermatology, (). http://dx.doi.org/10.1007/s40257-019-00446-6

Peer Reviewed

1